I don't believe that private delivery systems will be anxious to take on some of the high-cost services, such as expensive cancer treatments or transplant surgeries. They're more likely to look at what is profitable.

Obviously there will have to be operating cost dollars provided, because we wouldn't build them to see them sit idle.

We've got people waiting 18 months for surgery on their hips, ... And we have a demand for that type of service where they can pay for (the surgery) so they can get their life back.

It's saying, let's have a review of it. It's saying, let's do an economic modelling of it, so we know what would happen, ... It doesn't eliminate anything, but it doesn't close the door to changing the way we fund at least a part of health.

What happened in the States, while regrettable, I'm sure nobody regrets it more than that company, is something that I believe will not have a bearing on this file.

We're not closing the door to looking at the insurance-based model for one part or for several parts of the health-care system.

The vision is to have a strong public system, the vision is to make sure that there's health care when and where you need it, ... And we're paying attention.